ホーム>>Lipids>> Lipid-Based Drug Delivery>>cKK-E12

cKK-E12

カタログ番号GC52025

CKK-E12 は、RNA ベースの治療薬の送達に使用される脂質ナノ粒子を構成する他の脂質と組み合わせたイオン性脂質です。

Products are for research use only. Not for human use. We do not sell to patients.

cKK-E12 化学構造

Cas No.: 1432494-65-9

サイズ 価格 在庫数 個数
1 mg
$52.00
在庫あり
5 mg
$232.00
在庫あり
10 mg
$371.00
在庫あり
50 mg
$1,187.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com


顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of cKK-E12

cKK-E12 is an ionizable lipomer that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of mRNA.1

1.Hatit, M.Z.C., Lokugamage , M.P., Dobrowolski, C.N., et al.Species-dependent in vivo mRNA delivery and cellular responses to nanoparticlesNat. Nanotechnol.17(3)310-318(2022)

Chemical Properties of cKK-E12

Cas No. 1432494-65-9 SDF
Canonical SMILES O=C1NC(CCCCN(CC(CCCCCCCCCC)O)CC(CCCCCCCCCC)O)C(NC1CCCCN(CC(CCCCCCCCCC)O)CC(CCCCCCCCCC)O)=O
Formula C60H120N4O6 M.Wt 993.6
溶解度 DMSO : 50 mg/mL (50.32 mM; Need ultrasonic) Storage -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of cKK-E12

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 1.0064 mL 5.0322 mL 10.0644 mL
5 mM 0.2013 mL 1.0064 mL 2.0129 mL
10 mM 0.1006 mL 0.5032 mL 1.0064 mL
  • モルアリティ計算機

  • 希釈計算機

  • Molecular Weight Calculator

質量
=
濃度
x
容積
x
MW*
 
 
 
**ストックソリューションを準備する際には、常にバイアルラベルおよび MSDS/CoA(オンラインで利用可能)で掲載された製品のロット固有分子量を使用してください。

計算

In vivo Formulation Calculator (Clear solution) of cKK-E12

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

レビュー

Review for cKK-E12

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for cKK-E12

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.